Congenital thrombotic risk factors in β-Thalassemia

Clinical and Applied Thrombosis/Hemostasis

Volumn 15, Issue 5, 2009, Pages 581-584

  Sipahi, Tansu ^a   Kara, Aslihan ^a   Kuybulu, Ayca ^a   Egin, Yonca ^b   Akar, Nejat ^b  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Endothelial protein C receptor; Thalassemia; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5; CELL RECEPTOR; DEFEROXAMINE; ENDOTHELIAL CELL PROTEIN C RECEPTOR; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PROTEIN C; PROTEIN S; PROTHROMBIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; HEMATOLOGICAL PARAMETERS; HETEROZYGOSITY; HUMAN; IRON OVERLOAD; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SCHOOL CHILD; THROMBOEMBOLISM;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; PROTEIN C; PROTHROMBIN; RISK FACTORS; THROMBOEMBOLISM; YOUNG ADULT;

EID: 70449628222     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029608316170     Document Type: Article

References (24)

1. Ataga KI, Cappellini MD, Rachmilewitz EA B-Thalassemia and sickle cell anemia as paradigms of hypercoagulability. Br J Haematol. 2007 ; 139: 3-13.
2. Pignatti CB, Cornelli V., Caruso V., et al. Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol. 1998 ; 99: 76-79.
3. Cappelini MD, Grespi E., Cassinerio E., et al. Coagulation and splenectomy: an overview. Ann N Y Acad Sci. 2005 ; 1054: 317-324.
4. Akar N., Kemahl S., Akar E., et al. Common genetic variants in patients with chronic hemolytic disease and post splenectomy thrombotic events. Turk J Haematol. 1999 ; 16: 41-42.
5. Zurlo MG, De Stefano P., Pignatti B., et al. Survival and causes of death in thalassemia major. Lancet. 1989 ; 2: 27-30.
6. Michaeli J., Mittelman M., Grisaru D. Thromboembolic complications in beta thalassemia major. Acta Haematol. 1992 ; 87: 71-74.
7. Pignatti CB, Rugalotto S., De Stefano P., et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004 ; 89: 1187-1198.
8. Akar N., Kemahl S., Uysal Z., et al. Thromboembolism in β-thalassemia major. Acta Haematol. 1998 ; 100: 166.
9. Cappelini MD, Robbiolo L., Bottasso BM, et al. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassemia ±ntermedia. Br J Haematol. 2000 ; 111: 467-473.
10. Naithani R., Chandra J., Narayan S., et al. Thalassemia major on the verge of bleeding or thrombosis ? Hematology. 2006 ; 11: 57-61.
11. Kemahli, S., GÜrman C., Ein Y., et al. Hypercoagulability in children with thalassaemia major. Clin Appl Thromb Hemost. 1997 ; 3: 129-132.
12. Akar N., GOükdemir R., Özelzel D., et al. Endothelial cell protein C receptor (EPCR) gene exon III, 2 bp insertion mutation in the Turkish pediatric thrombotic patients. Thromb Haemost. 2002 ; 88: 1068.
13. Halley D., Eldor A., Girot R., et al. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and β-thalassemia. Thromb Haemost. 1996 ; 76: 322-327.
14. Kuypers FA, Yuan J., Rachel A., et al. Membrane phospholipid asymmetry in human thalassemia. Blood. 1998 ; 91: 3044-3051.
15. Eldor A., Durst R., Hyam E., et al. A chronic hypercoagulable state in patients with β-thalassemia major is already present in childhood. Br J Haematol. 1999 ; 107: 739-746.
16. Singer ST, Kuypers FA, Styles L., et al. Pulmonary hypertension in thalassemia; association with platelet activation and hypercoagulable state. Am J Hematol. 2006 ; 81: 670-675.
17. Finkelstein Y., Yaniv I., Berant M., et al. Central venous line thrombosis in children and young adults with thalassemia major. Pediatr Hematol Oncol. 2004 ; 21: 375-381.
18. Iolascon A., Giordano P., Storelli S., et al. Thrombophilia in thalassaemia major patients: analysis of genetic predisposition factors. Haematologica. 2001 ; 86: 1112-1113.
19. Zalloua PA, Shbaklo H., Mourad YA, et al. Incidence of thromboembolic events in Lebanese thalassemia inter-media patients. Thromb Haemost. 2003 ; 89: 767-768.
20. Akar N., Akar E., Dalg±n G., et al. Frequency of factor V (1691 G-A) mutation in the Turkish population. Thromb Haemost. 1997 ; 78: 1527-1529.
21. Akar N., M±s±rl±olu M., Akar E., et al. Prothrombin gene 20210 G-A mutation in the Turkish population. Am J Hematol. 1998 ; 58: 249.
22. GÜrgey A., Hicsonmez G., Parlak H., et al. Prothrombin gene 20210 G-A mutation in Turkish populations with thrombosis. Am J Hematol. 1998 ; 59: 179-180.
23. Saposnik B., Reny JL, Gaussen P., et al. A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis. Blood. 2004 ; 103: 1311-1318.
24. Ulu A., Gunal D., Tiras S., et al. EPCR gene A3 haplotype and elevated soluble endothelial protein C receptor (sEPCR) levels in Turkish pediatric stroke patients. Thromb Res. 2007 ; 120: 47-52.